Comprehensive Medical Weight Loss
semaglutide, tirzepatide, ozempic, wegovy, zepbound, mounjaro, liraglutide, and saxenda
Summer travel season is finally here! Whether you’re flying to the beach, road‑tripping to the mountains, or just spending extra time at backyard barbecues, vacations can test even the most committed weight‑loss plan. The good news? A little forethought goes…
GLP‑1 medications like semaglutide and tirzepatide are powerful tools for appetite control and metabolic health—but they’re not magic on their own. Long‑term success hinges on behavioral and lifestyle changes that lock in results even after you graduate from medication. Here…
GLP-1 medications like semaglutide and tirzepatide have revolutionized obesity treatment, helping patients achieve 10%-25% weight loss over one to two years. However, as with any medical weight-loss intervention, these medications are a tool—not a cure. Just as stopping blood pressure…
On February 21st, 2025, the FDA declared that semaglutide (Wegovy / Ozempic) is no longer in shortage. This will have significant impact for patients currently being treated with compounded semaglutide. Read on to learn more about this decision, and about…
FDA Approves Zepbound: A New Hope for Sleep Apnea Relief
On Thursday, 12/19/2024, the FDA declared that tirzepatide (Zepbound / Mounjaro) is no longer in shortage. This will have significant impact for patients currently being treated with compounded tirzepatide. Read on to learn more about this decision, and about your…
Tips to Gracefully Bid Farewell to GLP-1 Meds!
